- Patent Title: MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
-
Application No.: US16760396Application Date: 2018-11-02
-
Publication No.: US11497762B2Publication Date: 2022-11-15
- Inventor: Eljo Y. Van Battum , Vamshi R. Vangoor , Alwin A. H. A. Derijck , Roeland Quirinus Jozef Schaapveld , R. Jeroen Pasterkamp
- Applicant: INTERNA TECHNOLOGIES B.V.
- Applicant Address: NL Nijmegen
- Assignee: INTERNA TECHNOLOGIES B.V.
- Current Assignee: INTERNA TECHNOLOGIES B.V.
- Current Assignee Address: NL Nijmegen
- Agency: Much Shelist, PC
- Agent Christopher M. Cabral
- Priority: EP17199997 20171103
- International Application: PCT/EP2018/080007 WO 20181102
- International Announcement: WO2019/086603 WO 20190509
- Main IPC: A61K31/713
- IPC: A61K31/713 ; C12N15/113 ; C12Q1/68
Abstract:
The invention relates to the diagnostic and therapeutic uses of a miRNA molecule, an equivalent or a source thereof in a neuronal deficiency or a disease and condition associated with neuronal deficiency.
Public/Granted literature
Information query
